Patents
Patents for C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
02/2012
02/07/2012US8110404 Luminescent lanthanide binding chelates
01/2012
01/31/2012US8105567 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
01/10/2012US8093235 Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
01/05/2012US20120004206 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
12/2011
12/29/2011US20110315933 Materials for organic electroluminescent devices
11/2011
11/16/2011CN102245679A Method for using cyclic carbodimide
11/15/2011CA2477212C Novel arylamidine derivative or salt thereof
11/03/2011WO2011137190A1 Carbon supported tetraamido macrocyclic ligand catalytic activators and methods for making the same
11/01/2011US8048862 Macrocyclic inhibitors of hepatitis C virus replication
10/2011
10/27/2011WO2011069045A3 Synthesis of syrbactin proteasome inhibitors
10/20/2011US20110257145 Method of treating neurological diseases
10/18/2011US8039455 Macrocyclic compounds useful as BACE inhibitors
10/12/2011EP2374833A1 Method for using cyclic carbodimide
10/12/2011CN101389613B Macrocyclic factor viia inhibitors useful as anticoagulants
09/2011
09/29/2011WO2011050068A3 Bivalent diazo bicyclic smac mimetics and the uses thereof
09/28/2011EP2368886A1 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
09/15/2011US20110224184 Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis
09/14/2011EP1912997B1 Macrocyclic inhibitors of hepatitis c virus
09/09/2011WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE
09/06/2011US8013170 Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage
09/06/2011US8012969 11C-labeled benzyl-lactam compounds and their use as imaging agents
09/06/2011US8012939 Macrocyclic inhibitors of hepatitis C virus
08/2011
08/30/2011US8008250 Macrocyclic compounds and compositions useful as BACE inhibitors
08/24/2011EP2360208A1 Resin composition containing cyclic carbodimide
08/02/2011US7989471 Macrocyclic inhibitors of hepatitis C virus
07/2011
07/20/2011EP1481966B1 Novel arylamidine derivative or salt thereof
07/13/2011EP2343285A2 Peptoid compounds
07/05/2011CA2453845C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
06/2011
06/30/2011WO2011076674A1 New polyamide, polyimide or polyamide-imide comprising dibenzodiazocine units
06/14/2011US7960181 Chromoionophore and method of determining potassium ions
06/09/2011WO2011069045A2 Synthesis of syrbactin proteasome inhibitors
05/2011
05/31/2011US7951791 Amino-substituted tricyclic derivatives and methods of use
05/31/2011CA2429629C Ligand and complex for catalytically bleaching a substrate
05/26/2011WO2010081731A4 Derivatives of syringolin a
05/25/2011EP2324023A1 Vigor enhancement via administration of pyrimidine derivatives
05/19/2011WO2011058193A1 [1,5]-diazocin derivatives
05/19/2011CA2779088A1 [1,5]-diazocin derivatives
05/03/2011US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue
04/2011
04/28/2011WO2011050068A2 Bivalent diazo bicyclic smac mimetics and the uses thereof
04/14/2011US20110086858 Compounds for the Treatment of Hepatitis C
04/07/2011US20110082280 Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules
04/07/2011US20110081314 Antiviral phosphinate compounds
03/2011
03/31/2011US20110073331 Ionic Liquid Flame Retardants
03/24/2011WO2011034051A1 Novel cyclic squaramide derivatives
03/17/2011US20110065737 Hcv protease inhibitors
03/03/2011WO2010081731A3 Derivatives of syringolin a
03/03/2011US20110052528 Neuroprotective macrocyclic compounds and methods for their use
03/01/2011US7897590 Methods to mobilize progenitor/stem cells
02/2011
02/22/2011US7893223 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
02/17/2011US20110040087 Peptide turn mimetics
02/17/2011US20110039467 Ionic liquid flame retardants
02/16/2011EP2282762A2 Novel macrocyclic inhibitors of hepatitis c virus replication
02/02/2011EP1664092B1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
01/2011
01/26/2011EP1919898B1 Macrocyclic inhibitors of hepatitis c virus
01/25/2011US7875713 Synthetic binding pairs comprising cucurbituril derivatives and polyammonium compounds and uses thereof
01/19/2011EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds
01/12/2011EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds
01/05/2011EP1912999B1 Macrocyclic inhibitors of hepatitis c virus
12/2010
12/22/2010CN1988907B Dual small molecule inhibitors of cancer and angiogenesis
12/14/2010US7851621 Synthesis of deoxybiotinyl hexamethylenediamine-dota
09/2010
09/07/2010US7790394 Methods of analyzing a biological sample
08/2010
08/24/2010US7781425 Such as n-amidine substituted dibenz[c,e]azepines; synthesis; base catalysts for high yield nucleophilic type reactions
08/10/2010CA2451768C Peptoid compounds
08/05/2010US20100196316 Cyclosporin analogues for preventing or treating hepatitis c infection
07/2010
07/28/2010EP2210881A1 Derivatives of syringolin A
07/27/2010US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors
07/22/2010WO2010081731A2 Derivatives of syringolin a
07/13/2010US7754711 Pyridazine derivatives and their use as therapeutic agents
07/08/2010US20100173939 Antiviral compounds
07/01/2010US20100167995 Peptoid compounds
07/01/2010US20100166706 Hcv ns-3 serine protease inhibitors
06/2010
06/29/2010US7745619 alkaloids; anticarcinogenic, antiproliferative agent; inhibitor of cellular mitosis and cell proliferation; binding to tubulin leads to cell cycle arrest in M phase and subsequently to apoptosis; antiallergen, antiinflammatory, antidiabetic, autoimmune diseases; asthma, arthritis, Alzheimer' disease
06/24/2010WO2010071212A1 Method for using cyclic carbodimide
06/24/2010US20100160626 Process For The Preparation Of 3,7-Dihydroxy-1,5-Diazacyclooctanes
06/24/2010CA2745413A1 Method for using cyclic carbodimide
06/23/2010EP2197855A1 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods of preparation thereof
06/03/2010US20100137328 Tricyclic anilide heterocyclic cgrp receptor antagonists
06/02/2010CN1938280B Thiourea compositions and uses thereof
05/2010
05/27/2010WO2010017272A3 Method of treating neurological diseases
05/13/2010US20100120716 Macrocyclic hepatitis c serine protease inhibitors and uses therefor
05/06/2010US20100113488 Macrocyclic factor viia inhibitors useful as anticoagulants
05/06/2010US20100113440 Pyrimidine substituted macrocyclic hcv inhibitors
04/2010
04/27/2010CA2371816C Phthalamide-lanthanide complexes for use as luminescent markers
04/08/2010US20100086482 Divergent synthesis of looped poly(ester)-and poly(ether)-substituted dendrons and dendrimers
03/2010
03/30/2010US7687620 [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents
03/25/2010US20100076046 Antiviral Indoles
03/23/2010US7683168 Compositions of novel opioid compounds and method of use thereof
03/18/2010US20100069628 Multidentate AZA Ligands Able to Complex Metal Ions And The Use Thereof In Diagnostics And Therapy
03/18/2010US20100069351 Spiro compound and use thereof
03/17/2010EP1713822B1 Hcv ns-3 serine protease inhibitors
03/02/2010US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
02/2010
02/18/2010US20100041728 Hcv inhibiting macrocyclic phenylcarbamates
02/16/2010US7662812 disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances
02/11/2010WO2010017272A2 Method of treating neurological diseases
02/09/2010US7659393 Chemical intermediates of gadolinium complexes and cyclene ligand polyfunctinalized with carboxylate arms such as Dotarem, Prohance (gadoteridol) , andGadovist; one pot process of reacting ethyenediamine, glyoxal andbenzotriazole without using dibromo- or dichloroethane
02/04/2010US20100029715 Polymorphic forms of a macrocyclic inhibitor of hcv
01/2010
01/28/2010US20100022767 Development of a synthesis of syringolin a and b and derivatives thereof
01/28/2010US20100022578 Macrocyclic inhibitors of hepatitis c virus
01/28/2010US20100022500 Macrocyclic Lactams and Pharmaceutical Use Thereof
01/26/2010US7652003 Macrocyclic β-secretase inhibitors
1 2 3 4 5 6 7 8 9